Skip to contentClarengateINTELLIGENCE
Companies/NI072009

Exploristics Ltd

Private Limited Company · Belfast

OtherUnited KingdomIncorporated 2009Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2025-06-30

IXBRL · 149 source facts · 28 selected values

Validation findings
XBRL valid
Reporting period
2025-04-01 to 2025-06-30
Extraction status
complete
Numeric facts
91
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2024-01-01.xsd
Currency
GBP
Source identifier
Prod224_2602_NI072009_20250630
Source archive
Accounts_Monthly_Data-February2026.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2025-03-31

IXBRL · 162 source facts · 28 selected values

Validation findings
XBRL valid
Reporting period
2024-04-01 to 2025-03-31
Extraction status
complete
Numeric facts
104
Documents processed
1
XBRL standards validation
valid
Filing-profile validation
invalid
Parser
arelle 2.44.4
Taxonomy
FRS-102-2024-01-01.xsd
Currency
GBP
Source identifier
Prod224_2510_NI072009_20250331
Source archive
Accounts_Monthly_Data-October2025.zip

Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.

Accounts to 2024-03-31

IXBRL · 163 source facts · 28 selected values

Not assessed
legacy record
Reporting period
2023-04-01 to 2024-03-31
Extraction status
Legacy / not assessed
Numeric facts
107
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2021-01-01.xsd
Currency
GBP
Source identifier
Prod224_2366_NI072009_20240331
Source archive
Accounts_Monthly_Data-July2024.zip

Accounts to 2020-03-31

IXBRL · 82 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2019-04-01 to 2020-03-31
Extraction status
Legacy / not assessed
Numeric facts
46
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0086_NI072009_20200331
Source archive
Accounts_Monthly_Data-January2021.zip

Accounts to 2018-03-31

IXBRL · 82 source facts · 24 selected values

Not assessed
legacy record
Reporting period
2017-04-01 to 2018-03-31
Extraction status
Legacy / not assessed
Numeric facts
41
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0061_NI072009_20180331
Source archive
Accounts_Monthly_Data-December2018.zip

Accounts to 2013-03-31

IXBRL · 76 source facts · 16 selected values

Not assessed
legacy record
Reporting period
2012-04-01 to 2013-03-31
Extraction status
Legacy / not assessed
Numeric facts
32
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_9996_NI072009_20130331
Source archive
Accounts_Monthly_Data-November2013.zip

Accounts to 2010-03-31

XBRL · 34 source facts · 9 selected values

Not assessed
legacy record
Reporting period
— to —
Extraction status
Legacy / not assessed
Numeric facts
17
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-ae-2008-04-06.xsd
Currency
GBP
Source identifier
Prod224_9957_NI072009_20100331
Source archive
Accounts_Monthly_Data-August2010.zip

Registered details

NI072009
Status
Liquidation
Type
Private Limited Company
Incorporated
2009-03-12
Jurisdiction
—
Registered office
THE EWART, 4TH FLOOR, 3 BEDFORD SQUARE, BELFAST, BT27EP

Classification

1 SIC codes
23006

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

11 matched grants
Future Medicines Institute ApplicationActive
SiPF · Collaborative R&D · 2024-11-01 – 2029-10-31 · with 10 other participants
£34,567,860
whole project
Future Medicines Institute ApplicationLive
Innovate UK · Collaborative R&D · 2024-11-01 – 2029-10-31 · with 10 other participants
£0
awarded
Queen's University Belfastlead£20,737,174
Ulster University SIPF£3,188,359
Proaxsis Ltd£845,770
Exploristics Ltd£0
Expansion of a clinical trial modelling and simulation platform to optimise trial design and facilitate synthetic data generationLead
Innovate UK · Responsive Strategy and Planning · 2021-10-01 – 2023-03-31
£340,256
awarded
Transforming clinical research and development through the exploitation of patient level data sourcesLead
Innovate UK · Study · 2020-01-01 – 2021-07-31
£331,374
awarded
AI-driven business performance forecaster and plannerLead
Innovate UK · Innovation Loans · 2019-02-01 – 2021-07-31
£863,299
awarded
Development of a data repository for simulation of precision medicine studiesLead
Innovate UK · Collaborative R&D · 2017-08-01 – 2019-07-31
£450,816
awarded
Development of a data repository for simulation of precision medicine studies
ISCF · Collaborative R&D · 2017-07-31 – 2019-07-30
£450,816
whole project
Development of a data repository for simulation of precision medicine studiesLead
ISCF · Collaborative R&D · 2017-07-31 – 2019-07-30
£450,816
whole project
Feasibility study to develop a customised software platform for simulation of stratified medicine studies.Lead
Innovate UK · Feasibility Studies · 2016-03-01 – 2017-02-28 · with 1 other participant
£58,367
awarded
Exploristics Limitedlead£58,367
New software to optimise the design of Stratified Medicine and Benefit-Risk studiesLead
Innovate UK · Collaborative R&D · 2014-04-01 – 2017-03-31
£318,866
awarded
Feasibility study for the development of a software platform for the design of stratified medicine and benefit-risk studies.Lead
Innovate UK · Feasibility Studies · 2013-03-01 – 2013-10-31
£78,996
awarded